Home » The EMA releases Q&A on the use of real-world data
The European Medicines Agency (EMA) has published a Questions and Answers document aimed at clarifying and facilitating understanding of regulatory aspects addressed by existing EMA guidance on the use of real-world data.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.